Decibel Therapeutics raises $55m in new funding round

This article was originally published here

Decibel Therapeutics, a company focused on the discovery and development of medicines to treat hearing loss and hearing-related disorders, has raised $55m in a Series C financing.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply